ATG-Rituximab-MMF-TAC [clinicaltrials_resource:9f910c134fb2aa100e75eda8a0a7e643]
intervention [clinicaltrials_vocabulary:intervention]
ATG-Rituximab-MMF-TAC [clinicaltrials_resource:9f910c134fb2aa100e75eda8a0a7e643]
Bio2RDF identifier
9f910c134fb2aa100e75eda8a0a7e643
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9f910c134fb2aa100e75eda8a0a7e643
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
ATG-fresenium for max 6 consec ...... clinical implant in the liver.
intervention name [clinicaltrials_vocabulary:intervention-name]
ATG-Rituximab-MMF-TAC
identifier
clinicaltrials_resource:9f910c134fb2aa100e75eda8a0a7e643
title
ATG-Rituximab-MMF-TAC
@en
type
label
ATG-Rituximab-MMF-TAC [clinicaltrials_resource:9f910c134fb2aa100e75eda8a0a7e643]
@en